Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Vacationing on Mars
Hi Loyal Readers, Happy summer! Thanks for your visits all year. I’m on vacation this week, but I thought I’d leave you with something anyway. Next week, I’ll provide some more details about the upcoming blog carnival taking place August 29th. I hope you’ll drop by to read all the interesting blogs and different points […]
BRM2017: State of the regenerative medicine industry
Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His graduate research at Queen’s University, where he is pursuing a PhD in Chemical […]
Right Turn: ‘Right to try’ state of affairs in U.S.
On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that took on this cause in the first place. Earlier this month, the U.S. […]